Literature DB >> 15275050

A hypothesis about the chronicity of malaria infection.

P Druilhe1, J L Pérignon.   

Abstract

It is generally accepted that malaria evolves as a chronic blood infection by escaping the immune responses directed against a series of antigens that express variable epitopes and/or by selecting parasite populations with distinct polymorphic antigens. However, exacting in vitro studies, performed with clinically well-defined biological material, have correlated the state of protection of African adults (in whom low-grade infection persists) with an indirect defence mechanism where the antibodies are effective owing to their ability to cooperate with blood monocytes. Further studies showed that the antibody bridges the parasite (at the merozoite stage) with a monocyte and triggers the release of mediators which have a parasitistatic, reversible and non-antigen-specific effect. The fact that the parasite directly triggers the antiparasite effect leads Pierre Druilhe and Jean-Louis Pérignon to formulate here an alternative hypothesis for the chronicity of malaria infection, which would rely on conserved antigenic targets and, in contrast with direct mechanisms, would not select emerging mutated parasites. The above two mechanisms are discussed in the context of their fitness with clinical and parasitological observations. It is proposed that they are not mutually exclusive but, rather, may come into play successively as patients gradually evolve from high-grade symptomatic to low-grade asymptomatic parasitic infection.

Entities:  

Year:  1997        PMID: 15275050     DOI: 10.1016/s0169-4758(97)01095-8

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


  25 in total

1.  Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum.

Authors:  D R Cavanagh; C Dobaño; I M Elhassan; K Marsh; A Elhassan; L Hviid; E A Khalil; T G Theander; D E Arnot; J S McBride
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

2.  Levels of antibody to conserved parts of Plasmodium falciparum merozoite surface protein 1 in Ghanaian children are not associated with protection from clinical malaria.

Authors:  D Dodoo; T G Theander; J A Kurtzhals; K Koram; E Riley; B D Akanmori; F K Nkrumah; L Hviid
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Influence of antimalarial treatment on acquisition of immunity in Plasmodium berghei NK65 malaria.

Authors:  Ton That Ai Long; Shusuke Nakazawa; Maria Cecilia Huaman; Hiroji Kanbara
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

4.  Histopathological studies in two strains of semi-immune mice infected with Plasmodium berghei ANKA after chronic exposure.

Authors:  Gideon Kofi Helegbe; Tetsuo Yanagi; Masachika Senba; Nguyen Tien Huy; Mohammed Nasir Shuaibu; Akiko Yamazaki; Mihoko Kikuchi; Michio Yasunami; Kenji Hirayama
Journal:  Parasitol Res       Date:  2010-10-27       Impact factor: 2.289

5.  Toward the rational design of a malaria vaccine construct using the MSP3 family as an example: contribution of antigenicity studies in humans.

Authors:  Corine G Demanga; Lena-Juliette Daher; Eric Prieur; Catherine Blanc; Jean-Louis Pérignon; Hasnaa Bouharoun-Tayoun; Pierre Druilhe
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

6.  Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein.

Authors:  Soe Soe; Michael Theisen; Christian Roussilhon; Khin-Saw Aye; Pierre Druilhe
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Polymorphism of the Fcgamma receptor IIA and malaria morbidity.

Authors:  Erika Martins Braga; Kézia Katiani Gorza Scopel; Natália Tiemi Komatsu; Mônica da Silva-Nunes; Marcelo Urbano Ferreira
Journal:  J Mol Genet Med       Date:  2005-07-28

8.  Insights into the preclinical treatment of blood-stage malaria by the antibiotic borrelidin.

Authors:  I G Azcárate; P Marín-García; N Camacho; S Pérez-Benavente; A Puyet; A Diez; L Ribas de Pouplana; J M Bautista
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

9.  Prolonged Plasmodium falciparum infection in immigrants, Paris.

Authors:  Eric D'Ortenzio; Nadine Godineau; Arnaud Fontanet; Sandrine Houze; Olivier Bouchaud; Sophie Matheron; Jacques Le Bras
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

10.  Can prenatal malaria exposure produce an immune tolerant phenotype? A prospective birth cohort study in Kenya.

Authors:  Indu Malhotra; Arlene Dent; Peter Mungai; Alex Wamachi; John H Ouma; David L Narum; Eric Muchiri; Daniel J Tisch; Christopher L King
Journal:  PLoS Med       Date:  2009-07-28       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.